東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ subject:"Pharmacoeconomics and Health Outcomes." ]

切換: 標籤 | MARC模式 | ISBD

Health technology assessment in Japa...

Kamae, Isao.

FindBook

Google Book

Amazon

博客來

Health technology assessment in Japan = policy, pharmacoeconomic methods and guidelines, value, and beyond /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Health technology assessment in Japan/ by Isao Kamae.
其他題名:	policy, pharmacoeconomic methods and guidelines, value, and beyond /
作者:	Kamae, Isao.
出版者:	Singapore :Springer Singapore : : 2019.,
面頁冊數:	xvi, 269 p. :ill. (some col.), digital ;24 cm.
內容註:	1. Basics to Know -- 2. New HTA Policy in Japan -- 3. MHLW Guideline for Cost-effectiveness Analysis -- 4. How to Appraise -- 5. Exercises for Powerful Assessment -- 6. Intermediate Level Methods -- 7．Advanced Research Topics.
Contained By:	Springer eBooks
標題:	Medical economics. -
電子資源:	https://doi.org/10.1007/978-981-13-5793-0
ISBN:	9789811357930

Health technology assessment in Japan = policy, pharmacoeconomic methods and guidelines, value, and beyond /
Kamae, Isao.

Health technology assessment in Japanpolicy, pharmacoeconomic methods and guidelines, value, and beyond /[electronic resource] :by Isao Kamae. - Singapore :Springer Singapore :2019. - xvi, 269 p. :ill. (some col.), digital ;24 cm.

1. Basics to Know -- 2. New HTA Policy in Japan -- 3. MHLW Guideline for Cost-effectiveness Analysis -- 4. How to Appraise -- 5. Exercises for Powerful Assessment -- 6. Intermediate Level Methods -- 7．Advanced Research Topics.

Representing the first book on the topic, this work offers the reader an introduction to the Japanese systems for health technology assessment (HTA) officially introduced by the Ministry of Health, Labour and Welfare (MHLW) in 2016. Policy and guidelines are discussed, with the relevant methods and conditions of cost-effectiveness analysis explained alongside. Numerous instructive examples and exercises, ranging from basic to advanced, impart valuable knowledge and insight on the quantitative methods for economic evaluation, which will appeal to both beginners and experts. This guidebook is authored by Japan's foremost expert in HTA and pharmacoeconomics, with a view to strengthening the reader's expertise in value-based healthcare and decision-making. The methods presented are essential to informing regulatory, local and patient decisions; as such, the book is equally recommended to industry and government, as well as academia, and anyone with an interest in Japanese HTA.

ISBN: 9789811357930

Standard No.: 10.1007/978-981-13-5793-0doiSubjects--Topical Terms:

613524
Medical economics.

LC Class. No.: RA410 / .K35 2019

Dewey Class. No.: 338.473621

Health technology assessment in Japan = policy, pharmacoeconomic methods and guidelines, value, and beyond /
LDR:02295nmm a2200337 a 4500 001 2192734
003 DE-He213
005 20191029012803.0
006 m d
007 cr nn 008maaau
008 200508s2019 si s 0 eng d
020 $a 9789811357930 $q (electronic bk.)
020 $a 9789811357923 $q (paper)
024 7 $a 10.1007/978-981-13-5793-0 $2 doi
035 $a 978-981-13-5793-0
040 $a GP $c GP
041 1 $a eng $h jpn
050 4 $a RA410 $b .K35 2019
072 7 $a KCQ $2 bicssc
072 7 $a BUS069000 $2 bisacsh
072 7 $a KCVJ $2 thema
082 0 4 $a 338.473621 $2 23
090 $a RA410 $b .K15 2019
100 1 $a Kamae, Isao. $3 3413357
240 1 0 $a Iryougijyutuhyouka Waakubukku. $l English
245 1 0 $a Health technology assessment in Japan $h [electronic resource] : $b policy, pharmacoeconomic methods and guidelines, value, and beyond / $c by Isao Kamae.
260 $a Singapore : $b Springer Singapore : $b Imprint: Adis, $c 2019.
300 $a xvi, 269 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a 1. Basics to Know -- 2. New HTA Policy in Japan -- 3. MHLW Guideline for Cost-effectiveness Analysis -- 4. How to Appraise -- 5. Exercises for Powerful Assessment -- 6. Intermediate Level Methods -- 7．Advanced Research Topics.
520 $a Representing the first book on the topic, this work offers the reader an introduction to the Japanese systems for health technology assessment (HTA) officially introduced by the Ministry of Health, Labour and Welfare (MHLW) in 2016. Policy and guidelines are discussed, with the relevant methods and conditions of cost-effectiveness analysis explained alongside. Numerous instructive examples and exercises, ranging from basic to advanced, impart valuable knowledge and insight on the quantitative methods for economic evaluation, which will appeal to both beginners and experts. This guidebook is authored by Japan's foremost expert in HTA and pharmacoeconomics, with a view to strengthening the reader's expertise in value-based healthcare and decision-making. The methods presented are essential to informing regulatory, local and patient decisions; as such, the book is equally recommended to industry and government, as well as academia, and anyone with an interest in Japanese HTA.
650 0 $a Medical economics. $3 613524
650 0 $a Medical care, Cost of $z Japan. $3 780764
650 0 $a Health care reform $z Japan. $3 780763
650 1 4 $a Health Economics. $3 820895
650 2 4 $a Pharmacoeconomics and Health Outcomes. $3 2089175
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-981-13-5793-0
950 $a Medicine (Springer-11650)